Table 2.
Baseline characteristics in retreatment PTB patients with different treatment outcomes
| Characteristics | Study population | Treatment failure (n = 99) | Treatment success (n = 296) |
|---|---|---|---|
| (n = 395) | |||
| Age (years) | 43 (31·75–53·00) | 41 (31·00–52·00) | 46 (37·00–54·00) |
| Gender | |||
| Male | 300 (75·9) | 76 (25·3) | 224 (74·7) |
| Female | 95 (24·1) | 23 (24·2) | 72 (75·8)) |
| Drug susceptibility | |||
| Drug resistance | 185 (48·8) | 58 (31·4) | 127 (68·6) |
| Drug sensitivity | 194 (51·2) | 35 (18·0) | 159 (82·0) |
| BMI (kg/m2) | |||
| <18·5 | 105 (26·9) | 34 (32·4) | 71 (67·6) |
| ⩾18·5 | 286 (73·1) | 64 (22·4) | 222 (77·6) |
| Household register | |||
| Local residence | 275 (69·6) | 66 (24·0) | 209 (76·0) |
| Non-local residence | 120 (30·4) | 33 (27·5) | 87 (72·5) |
| Ethnicity | |||
| Han | 374 (94·7) | 94 (25·1) | 280 (74·9) |
| Minorities | 21 (5·3) | 5 (23·8) | 16 (76·2) |
| Level of education | |||
| Low | 349 (88·4) | 96 (27·5) | 253 (72·5) |
| High | 46 (11·6) | 3 (6·5) | 43 (93·5) |
| Marital status | |||
| Single | 77 (19·5) | 16 (20·8) | 61 (79·2) |
| Married | 301 (76·2) | 79 (26·2) | 222 (73·8) |
| Others | 17 (4·3) | 4 (23·5) | 13 (76·5) |
| Smoking status | |||
| No smoking | 168 (42·9) | 37 (22·0) | 131 (78·0) |
| Former smoking | 167 (42·6) | 44 (26·3) | 123 (73·7) |
| Current smoking | 57 (14·5) | 17 (29·8) | 40 (70·2) |
| Alcohol use | |||
| No drinking | 216 (55·2) | 48 (22·2) | 168 (77·8) |
| Former drinking | 154 (39·4) | 41 (26·6) | 113 (73·4) |
| Current drinking | 21 (5·4) | 9 (42·9) | 12 (57·1) |
| History of BCG vaccination | |||
| Yes | 196 (49·7) | 40 (20·4) | 156 (79·6) |
| No | 198 (50·3) | 59 (29·8) | 139 (70·2) |
| Previous treatment duration | |||
| ⩽6 months | 232 (59·2) | 51 (22·0) | 181 (78·0) |
| >6 months | 160 (40·8) | 48 (30·0) | 112 (70·0) |
| Number of treatment | |||
| 1 | 349 (88·4) | 82 (23·5) | 267 (76·5) |
| ⩾2 | 46 (11·6) | 17 (37·0) | 29 (63·0) |
| Retreatment type | |||
| Relapse | 251 (63·5) | 58 (23·1) | 193 (76·9) |
| Initial treatment failure | 67 (17·0) | 13 (19·4) | 54 (80·6) |
| Others | 77 (19·5) | 28 (36·4) | 49 (63·6) |
| Complications | |||
| Yes | 93 (24·0) | 26 (28·0) | 67 (72·0) |
| No | 294 (76·0) | 72 (24·5) | 222 (75·5) |
| Adverse reaction this time | |||
| Yes | 95 (24·1) | 29 (30·5) | 66 (69·5) |
| No | 300 (75·9) | 70 (23·3) | 230 (76·7) |
| Treatment regimen | |||
| Standard regimen | 110 (27·8) | 42 (38·2) | 68 (61·8) |
| Optimal regimen | 285 (72·2) | 57 (20·0) | 228 (80·0) |
| Culture result after 2 months of treatment | |||
| Negative | 302 (79·7) | 56 (18·5) | 246 (81·5) |
| Positive | 77 (20·3) | 32 (41·6) | 45 (58·4) |